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Abstract
Background: NHS Stop Smoking Services provide various options for support and counselling. Most services have
evolved to suit local needs without any retrospective evaluation of their efficiency.
Three local service evaluations were carried out at Bournemouth & Poole Teaching Primary Care Trust (PCT) (PCT1),
NHS South East Essex (PCT2) and NHS Warwickshire (PCT3) to describe the structure and outcomes associated with
different services.
Result: Standardised interviews with key personnel in addition to analysis of data from 400 clients accessing the
service after 1
st April 2008 in each PCT. The PCTs varied in geography, population size and quit rate (47%-63%).
Services were delivered by PCT-led specialist teams (PCT1), community-based healthcare providers (PCT3) and a
combination of the two (PCT2) with varying resources and interventions in each.
Group support resulted in the highest quit rates (64.3% for closed groups v 42.6% for one-to-one support (PCT1)).
Quit rates were higher for PCT (75.0%) v GP (62.0%) and pharmacist-delivered care (41.0%) where all existed in the
same model (PCT2). The most-prescribed therapy was NRT (55.8%-65.0%), followed by varenicline (24.5%-34.3%),
counselling alone (6.0%-7.8%) and bupropion (2.0%-4.0%).
Conclusion: The results suggest that service structure, method of support, healthcare professional involved and
pharmacotherapy all play a role in a successful quit. Services must be tailored to support individual needs with
patient choice and access to varied services being key factors.
Keywords: Smoking cessation, Service structure, Service development, Nicotine replacement therapy, Varenicline,
Bupropion
Background
The effects of cigarette smoking on individual health [1],
the health service [2] and the economy [3] are well-
documented. In view of this wide-ranging impact, a pre-
vious UK government funded a comprehensive National
Health Service (NHS) Stop Smoking Service with a tar-
get of reducing the number of adult smokers to 21% or
fewer by 2010 [4]. The current Tobacco Control Plan
for England includes clear goals to reduce adult smoking
prevalence from 21% to 18.5%, smoking rates among 15
year olds from 15% to 12% and smoking in pregnancy
from 14% to 11% by 2015 [5]. The NHS is free at the
point of delivery and funded by taxation.
NHS Stop Smoking Services [4] are now available
throughout the NHS in England, providing counselling,
behavioural support and medications to smokers want-
ing to quit. Smokers accessing these services are given
various options [4] for the type of support and counsel-
ling they wish to receive. While most smoking cessation
services offer both one-to-one support and sessions run
in groups, the latter may be either open/rolling (people
joining and leaving all at different stages of the quit pro-
cess) or closed (all participants at the same stage of the
quit process) and in some cases may be delivered in
large workplaces (’workplace groups’). Support may be
delivered centrally by Primary Care Trust (PCT)-based
smoking cessation advisors or may be commissioned
from GPs, nurses and pharmacists in the community.
The majority of services have evolved their structure
over time, to suit local needs, without evaluating
whether the service is operating in the best possible
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cological therapies including nicotine replacement ther-
apy (NRT), bupropion and varenicline. In the UK, NRT
can be purchased from pharmacies without a prescrip-
tion, and so can be provided by nurses and pharmacists
providing a smoking cessation service, while the other
therapies are available only with a physician’s
prescription.
Data are routinely collected to allow the Department
of Health to evaluate the Stop Smoking Service. Quit
rates are reported by the NHS Information Centre [6]
by gender, age, ethnic group, pregnancy and geographi-
cal area, but not by structure of the service, which dif-
fers significantly between PCTs.
This series of service evaluations describe the
resources used and outcomes associated with differ-
ently-structured services within three PCTs: Bourne-
mouth & Poole Teaching PCT (PCT1), NHS South East
Essex (PCT2) and NHS Warwickshire (PCT3).
Methods
Local service evaluations were conducted separately in
three PCTs between January and September 2009 by an
independent healthcare evaluation consultancy, using
the same methods for each one. No approval was sought
from a Research Ethics Committee nor consent from
clients as it is required only for research and not service
evaluations in the UK. Each Trust did however gain
Trust management approval to take part in the evalua-
tion and to release anonymised data. Locally and nation-
ally published statistics [7-18] were used to obtain local
population demographics so that the structure and out-
comes of each service could be set in its local context.
A description of each service and the staff resources
providing it was obtained by conducting interviews with
smoking cessation service staff. The service manager
was interviewed in all three PCTs to obtain information
on the structure of the service, while a selection of key
staff providing the service were asked for estimates of
the average staff time involved in a quit attempt. Stan-
dardised interview guides for the service lead and for
service representatives were used to ensure consistency
between interviews, and responses were documented by
the interviewer during the interview. Interviews were
not audio or video recorded as the data collected was
factual and was easily recorded onto a proforma.
Patient level data from each of the smoking cessation
services were obtained retrospectively from 400 client
records from each PCT. The first 400 clients accessing
the service after 1st April 2008 were included in the
review at each PCT. This represented 13.0%, 7.3% and
6.3% of all people from PCT1, PCT2 and PCT3 respec-
tively that set a quit date from April 2008 to March
2009 with the NHS Stop Smoking Service [19]. Data
were collected by PCT staff from electronic records and
the DoH ‘Gold standard’ service monitoring forms.
Anonymised-coded data on client demographics, chosen
service provider and intervention and quit attempt out-
comes were provided to the consultancy for analysis
using Microsoft Excel™ and reporting back to each
PCT.
Results
The numbers and professions of the service provider
staff interviewed varied according to the structure of the
service described by the manager: in PCT1, three smok-
ing cessation advisors, in PCT2, three advisors, four
pharmacists and two practice nurses and in PCT3, three
pharmacists and two practice nurses were interviewed.
Description of service
PCT1 covers a population of 301,732 [20] in an area of
just 42.9 square miles [21], where an estimated 20%
[22,23] of people smoke and health is generally similar
to the national average (Bournemouth) or above average
(Poole). At the time of evaluation the smoking cessation
service was being delivered by a PCT-led specialist
smoking cessation team (See Table 1) by means of a
choice of group and one-to-one support (Table 1). This
smoking cessation service was accessed by 3076 people
from April 2008 to March 2009 [23].
PCT2 covers a population of 325,354 [24] in an area
of 98.1 sq miles [25], where approximately 21.4% [26] of
people smoke and overall health is similar to (Southend-
on-sea) or better than (Castle Point & Rochford) the
English national average. The smoking cessation service
is PCT-led by a specialist smoking cessation team but
delivered by a combination of the PCT team and general
practices, pharmacies, dentists and opticians (See Table
1) employing both one to one and group support (Table
1). The PCT2 smoking cessation service was accessed by
5497 people from April 2008 to March 2009 [27].
PCT3 covers a population of 505,860 [28] in an area
of 736 square miles [29], where approximately 23% [30]
of people smoke and people’s health is generally better
than the average for England, apart from Nuneaton and
Bedworth where it is worse than average. The stop
smoking service was delivered to 6348 people from
April 2008 to March 2009 [31] by local healthcare pro-
fessionals (Table 1). Support is primarily by one to one
support (Table 1), rather than in groups. There is little
or no direct contact with smokers by the centralised
PCT team, whose main role is training and support of
the service providers.
Client access to support
In both PCT1 and PCT2, where clients can access either
one to one or group support, the latter yielded the
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rates (54.9% and 76.2% for group support vs 42.6% and
51.2% for one to one support in PCT1 and PCT2
respectively; Table 2). However, in PCT3, where only
one to one support is provided, a similar quit rate to
the PCT1 group support quit rate was achieved (PCT3
one to one support 55.8% vs PCT1 group support
54.9%) (Table 2). Of the different types of group support
offered in PCT1, the workplace groups produced the
highest quit rate (though absolute numbers were small)
of 64.3%, but an even higher quit rate was achieved with
closed groups in PCT2 (76.2%) (Table 2). To put this
into perspective, national figures for April 2008 to
March 2009 give a quit rate of 49% for one to one sup-
port, 64% for closed groups and 55% for rolling groups
[32].
Where PCT and community delivered services exist
within the same model of provision (i.e. PCT2; Table 1),
four-week quit rates were higher within the PCT deliv-
ered services (75.0% quit rate for PCT care vs 62.0%
quit rate for GP-delivered care and 41.0% quit rate for
pharmacist-delivered care).
Table 1 Staffing structure of smoking cessation service in 3 PCTs
PCT PCT1 PCT2 PCT3
Service model PCT provided Combination PCT & HCP provided HCP provided
PCT Staffing 1 clinical specialist lead (1.0 whole
time equivalents (WTE))
3 administrators (3.0 WTE)
1 co-ordinator/advisor (1.0 WTE)
6 advisors (5.91 WTE) band 5/6 - core
team
1 smoking and pregnancy advisor
(0.8 WTE)
1 maternity support worker (0.2 WTE)
10 bank staff (total 0.5 WTE)
1 WTE Service Manger vacancy
1 Stop smoking service & tobacco control
manager (1.0 WTE)
2 administrators (1.5 WTE)
Stop smoking advisors (2.5 WTE)
1 smoking and pregnancy advisor (0.5
WTE)
Primary care facilitators (1.5 WTE)
1 Secondary care stop smoking advisor
(0.5 WTE)
Trainers (2.0 WTE)
Stop smoking sessional advisors, ad hoc to
service need. (1.5 WTE)
1 Smoking Cessation (SC) Manager
(1.0 WTE)
1 Data & Information Assistant (1.0
WTE)
1 Finance & Training Administrator
(0.45 WTE)
5 Advisors (3.7 WTE)
3 Pregnancy SC Advisors (1.5 WTE)
1 Tobacco Control Co-ordinator (0.5
WTE) (Public Health)
Total PCT WTE 12.41 11.0 8.15
Other providers None GP Practices n=68
Pharmacies n=61
Dental practices n=3
Opticians n=2
GP practices n=76
Pharmacies n =49
Dental practices n=2
Total other providers 0 134 127
Intervention type:
One to one 263 (65.7%) 211 (52.8%) 396 (99.0%)
Groups 133 (33.3%) 185 (46.3%) 0
Other (drop-in, telephone,
family/couple)
4 (1.0%) 4 (1.0%) 4 (1.0%)
Table 2 Four week (CO validated) quit rate by service provider and intervention type
PCT1 PCT2 PCT3
Service provider
PCT 46.8% 75.0% -
GP - 62.0% 58.2%
Pharmacist - 41.0% 43.0%
Intervention type
One to one 112/263 (42.6%) 108/211 (51.2%) 221/396 (55.8%)
Closed group 8/17 (47.1%) 141/185 (76.2%) -
Rolling group 47/88 (53.4%) - -
Workplace group 18/28 (64.3%) - -
Total - all groups 73/133 (54.9%) 141/185 (76.2%) -
Other (drop in, telephone, family/couple) 2/4 (50.0%) 4/4 (100.0%) 4/4 (100.0%)
Overall 4-week quit rate 187/400 (46.8%) 253/400 (63.3%) 225/400 (56.3%)
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In terms of prescriptions, all agents were available for
first line use in each of the Trusts - there were no pre-
scribing restrictions in place at the time of data collec-
tion. The most commonly used pharmacotherapy was
nicotine replacement therapy (NRT) (PCT1, 65.0%;
PCT2, 55.8%; PCT3, 63.5%), followed by varenicline
(PCT1, 24.5%; PCT2, 34.3%; PCT3, 25.5%) and bupro-
pion (PCT1, 2.8%; PCT2, 4.0%; PCT3, 2.0%). In PCT1,
over half (56.9%) of those using NRT used combination
NRT, as they were assessed as being complex clients
with high nicotine addiction. This data was not available
for the other PCTs. Within each PCT, a consistently
small number of clients chose to attempt to quit with
counselling alone (PCT1, 6.0%; PCT2, 5.8%; PCT3,
7.8%). These figures are largely in line with the national
average during the year April 2008 to March 2009
w h e r e6 7 %o fp e o p l ew h os e taq u i td a t ew e r ep r e -
scribed NRT, 20% varenicline, 2% bupropion and 5%
opting for no therapy [33].
Quit rates associated with pharmacotherapy interven-
tions are shown in Table 3. Quit rates associated with
NRT ranged between 40.0% and 54.3%; between 60.2%
and 81.0% for varenicline; and between 37.5% and 90.9%
for bupropion, although numbers for the latter are small
across all three PCTs. Quit rate in those opting to
attempt to quit with counselling alone ranged from
35.5% to 56.5%. Pharmacological support provided var-
ied across service providers (PCT, GP, pharmacist), with
pharmacists tending to prescribe mainly NRT (100.0%
of pharmacist prescribing in PCT2, 87.3% in PCT3) and
the highest proportion of varenicline being prescribed
by PCT employed smoking cessation advisors (56.0% of
PCT prescribing was for varenicline versus 25.0% of GP
prescribing within PCT2). Prescribing also differed
across service delivery settings, with PCT2 showing
more varenicline prescribing within the group setting
(58.4% of clients setting a quit date within a group) than
clients attempting to quit with one to one support
(12.3%). Bupropion was rarely used (2.9% of quitters
overall, 0-7.0%, depending on the provider).
Discussion
This retrospective evaluation of smoking cessation ser-
vices in 3 English PCTs shows that the context of these
services varies widely between PCTs. The general health
of the populations in these 3 PCTs did not differ widely
from the national average. However, the prevalence of
smoking ranged from 20% to 23%. The area covered by
the PCT ranged from just 43 square miles in PCT1 to
736 square miles in PCT3, and the populations served
ranged from 300,000 to over 500,000. All these differ-
ences have informed the development of the varying
models of smoking cessation service in order to meet
the needs of the local population.
The lower rates of smoking prevalence in PCT1,
which follow several years of declining prevalence, may
suggest that those who are more motivated to quit have
already done so. Hence the service provided in PCT1 by
specialised stop smoking Advisers, with a wide choice of
different interventions is needed for continuing success
with remaining smokers who may have more complex
needs. This need for specialist advisors is likely to
become increasingly important as prevalence rates con-
tinue to be driven down.
Conversely, in PCT3, which covers a large geographi-
cal area, it is not feasible to provide group support to
the widely dispersed, predominantly rural population.
As such, the service is appropriately composed almost
exclusively of one to one support provided by GP prac-
tices and pharmacies, with emphasis on specialist advi-
sors providing high quality training and support to
those delivering the service.
The 4-week quit rates for all types of intervention
were greater than 40.0%, with overall quit rates aver-
aging 46.8% to 63.3% across the PCTs. Quit rates var-
ied between types of intervention, ranging from 42.6%
for one to one support to 64.3% for closed groups in
PCT1.
The 4-week quit rates also varied between the PCTs
for similar types of intervention; e.g. one to one support
produced quit rates ranging from 42.6% (PCT1) to
55.8% (PCT3), while group support quit rates ranged
from 47.1% (PCT1) to 76.2% (PCT2). The quit rates for
one to one support are similar to the national average
for 2010 (49%) [33]. However, in terms of group sup-
port, PCT1 had quit rates (54.9%) that were generally
slightly lower and PCT2 had quit rates that were slightly
higher (76.2%) than the national average (64%) [34].
The data suggest that, whilst group support can be an
efficient and effective method, it does produce variable
results which may depend on the type of client (e.g.
more or less motivated), staff and geographical setting
of the service. These factors need to be considered
when planning a service model.
Table 3 Four week quit rate by pharmacological
intervention (denominator n = number clients setting
quit date)
PCT1 PCT2 PCT3
NRT 40.0% (104/260)* 52.0% (116/223) 54.3% (138/254)
Varenicline 60.2% (59/98) 81.0% (111/137) 68.6% (70/102)
Bupropion 90.9% (10/11) 75.0% (12/16) 37.5% (3/8)
None 41.6% (10/24) 56.5% (13/23) 35.5% (11/31)
*This result represents a combination of monotherapy (53/112; 47%) and dual
therapy (51/148; 34%).
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of counselling provided, pharmacotherapies offer impor-
tant support to those quitters wishing to utilise them.
Across all PCTs, NRT was most commonly prescribed
(quit rate range 40.0-54.3%), followed by varenicline
(quit rate range 60.2-81.0%), and then bupropion (quit
rate range 37.5-90.9%). The quit rate range for quitters
using counselling alone was 35.5-56.5% across the PCTs
although it is likely that these are the most motivated
patients and, although the data was not collected, it
would be interesting to assess whether these were also
clients attempting to quit for the first time.
Clearly there are limitations within this service evalua-
tion dataset and in future work it would be useful to
collect levels of deprivation and dependence and socio-
economic factors to allow statistical analysis and further
conclusions to be drawn as to the most appropriate ser-
vice/intervention for specific client profiles. In addition,
more robust data allowing for the comparison of differ-
ent models of provision is needed to enable Stop Smok-
ing Services to offer the most cost effective service for
their local population.
Conclusion
It is clear from the complexity of the results that quit
rates associated with smoking cessation are multifactor-
ial, with service structure, method of support delivery,
healthcare professional involved and pharmacological
support all playing a significant and important role in a
quit attempt. The same models of service provision
within different PCTs yield different quit rates. This is
in line with recent research which reported substantial
variation in success rates across intervention characteris-
tics even after adjusting for smoker characteristics [35].
Clearly no single service will suit all and clients attempt-
ing to stop smoking need to be provided with support
tailored to their individual needs. Patient choice and
access to varied services is a key factor for
consideration.
This evaluation has provided a useful benchmarking
exercise, allowing for between-PCT descriptions of local
service provision and patterns of service use to emerge,
and highlighting areas for further investigation for
potential service quality improvements. However, the
findings need to be understood within the context of
local health geography challenges and different client
mixes. Stop Smoking Services with specialist knowledge
of these factors are essential if smoking rates are to con-
tinue to be successfully reduced in future.
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